Comparison of antimicrobial activities of natural essential oils and synthetic fragrances against selected environmental pathogens

Por Vieira-Brock, Paula L., Vaughan, Brent M., Vollmer, David L.
Publicado no Biochim Open (2017)

Methamphetamine self-administration attenuates hippocampal serotonergic deficits: Role of brain derived neurotrophic factor

Por McFadden, Lisa M., Vieira-Brock, Paula L., Hanson, Glen R., Fleckenstein, Annette E.
Publicado em 2014

Prior Methamphetamine Self-Administration Attenuates the Dopaminergic Deficits Caused by a Subsequent Methamphetamine Exposure

Por McFadden, Lisa M., Vieira-Brock, Paula L., Hanson, Glen R., Fleckenstein, Annette E.
Publicado no Neuropharmacology (2015)

Simultaneous quantification of nicotine and metabolites in rat brain by liquid chromatography tandem mass spectrometry

Por Vieira-Brock, Paula L, Miller, Eleanor I, Nielsen, Shannon M, Fleckenstein, Annette E, Wilkins, Diana G
Publicado em 2011

Age-Related Differences in the Disposition of Nicotine and Metabolites in Rat Brain and Plasma

Por Vieira-Brock, Paula L., Andrenyak, David M., Nielsen, Shannon M., Fleckenstein, Annette E., Wilkins, Diana G.
Publicado em 2013

Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition Deficits

Por Vieira-Brock, Paula L., McFadden, Lisa M., Nielsen, Shannon M., Smith, Misty D., Hanson, Glen R., Fleckenstein, Annette E.
Publicado no Int J Neuropsychopharmacol (2015)

Prior Methamphetamine Self-Administration Attenuates Serotonergic Deficits Induced by Subsequent High-Dose Methamphetamine Administrations

Por McFadden, Lisa M., Hunt, Madison M., Vieira-Brock, Paula L., Muehle, Janice, Nielsen, Shannon, Allen, Scott C., Hanson, Glen R., Fleckenstein, Annette E.
Publicado em 2012

Methamphetamine Self-Administration Acutely Decreases Monoaminergic Transporter Function

Por McFadden, Lisa M., Stout, Kristen A., Vieira-Brock, Paula L., Allen, Scott C., Nielsen, Shannon M., Wilkins, Diana G., Hanson, Glen R., Fleckenstein, Annette E.
Publicado em 2011

Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits

Por Vieira-Brock, Paula L., McFadden, Lisa M., Nielsen, Shannon M., Ellis, Jonathan D., Walters, Elliot T., Stout, Kristen A., McIntosh, J. Michael, Wilkins, Diana G., Hanson, Glen R., Fleckenstein, Annette E.
Publicado no J Pharmacol Exp Ther (2015)

Methamphetamine Self-Administration Causes Persistent Striatal Dopaminergic Alterations and Mitigates the Deficits Caused by a Subsequent Methamphetamine Exposure

Por McFadden, Lisa M., Hadlock, Greg C., Allen, Scott C., Vieira-Brock, Paula L., Stout, Kristen A., Ellis, Jonathan D., Hoonakker, Amanda J., Andrenyak, David M., Nielsen, Shannon M., Wilkins, Diana G., Hanson, Glen R., Fleckenstein, Annette E.
Publicado em 2012

Methamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high-dose methamphetamine administration

Por McFadden, Lisa M, Hoonakker, Amanda J, Vieira-Brock, Paula L, Stout, Kristen A, Sawada, Nicole M, Ellis, Jonathan D, Allen, Scott C, Walters, Elliot T, Nielsen, Shannon M, Gibb, James W, Alburges, Mario E, Wilkins, Diana G, Hanson, Glen R, Fleckenstein, Annette E
Publicado em 2011

4-Methylmethcathinone (Mephedrone): Neuropharmacological Effects of a Designer Stimulant of Abuse

Por Hadlock, Gregory C., Webb, Katy M., McFadden, Lisa M., Chu, Pei Wen, Ellis, Jonathan D., Allen, Scott C., Andrenyak, David M., Vieira-Brock, Paula L., German, Christopher L., Conrad, Kevin M., Hoonakker, Amanda J., Gibb, James W., Wilkins, Diana G., Hanson, Glen R., Fleckenstein, Annette E.
Publicado em 2011